World Class Speakers

 

The HPAPI Wolrd Congress agenda will feature 300+ speakers across multiple streams and co-located events.

Speakers will come from the most successful, innovative and thought-provoking companies from around the world. They will be supported by leading suppliers from the mega tech companies to the latest start-ups who are shaking up the industry.

 

2018 Speakers confirmed to date

 

Jenny Alltoft, Head of Global Biosimilars, Pfizer

Jenny Alltoft at HPAPI World Congress

Martin Axon, Principal, Occupational Hygienist of Operations for Europe, Safebridge

Martin Axon at HPAPI World Congress

Dani Bach, Director, Healthcare Ventures, Touchstone Ventures

Dani Bach at HPAPI World Congress

Jonathan Back, Deputy Director, Project Team Lead, Drug Discovery, Glenmark Pharmaceuticals SA

Jonathan Back at HPAPI World Congress

Dr Roy Baynes, SVP of Head Global Clinical Development, Chief Medical Officer, Merck Sharp and Dohme (MSD)

Karoline Bechtold Peters, Senior Strategy & Technology Leader - Pharmaceutical Development, Novartis

Karoline Bechtold Peters at HPAPI World Congress

Dr Alain Beck, Senior Director, NBEs Analytical Chemistry, Centre d'Immunologie Pierre Fabre

Stephen Beers, Associate Professor, University Of Southampton

Phil Bland-Ward, Chief Scientific Officer, Crescendo Biologics Ltd

Phil Bland-Ward at HPAPI World Congress

Dr Ezio Bonvini, CSO, Macrogenics

Louis Boon, Chief Scientific Officer, Bioceros

Ingrid Bourges, Clinical Assessor, Federal Agency for Medicines and Health Products

Ingrid Bourges at HPAPI World Congress

Frank Brennan, Head of Non-Clinical Toxicology and PK/PD (Immunology), UCB Pharma

Alessandro Brigo, Principal Scientist in Pharma Research and Early Development and Toxicology Project Leader, Roche Pharmaceuticals

Alessandro Brigo at HPAPI World Congress

Dr Ulrich Brinkmann, Scientific Director, Expert Scientist, Roche

Jack Brown, Senior Principal Scientist, Boehringer Ingelheim Pharmaceuticals Inc

Jack Brown at HPAPI World Congress

Sebastian Bunk, Research Director, Immunology, Immatics Biotechnologies GmbH

Patrick Burke, Associate Director, Seattle Genetics Inc

Martina Canestraro, Senior Scientist Cell Biology, Immunocore Ltd

Paul Carter, Senior Director and Staff Scientist, Antibody Engineering, Genentech

Kieran Casey, Business Development Manager, Services, Bioreclamation IVT

Brian Champion, CSO, Psioxus Therapeutics Ltd

Brian Champion at HPAPI World Congress

Deborah Charych, Executive Director, Nektar Therapeutics

Deborah Charych at HPAPI World Congress

Andre Choo, Principal Scientist and Director, Antibody Discovery, Bioprocessing Technology Institute

Andre Choo at HPAPI World Congress

Partha Chowdhury, Senior Director and Head, Antibody Discovery, Sanofi Genzyme

Partha Chowdhury at HPAPI World Congress

Daniela Cipolletta, Investigator III, Novartis

Jeannick Cizeau, Director of Research, Eleven Biotherapeutics

Nathalie Corvaïa, Managing Director, Institut De Recherche Pierre Fabre

Nathalie Corvaïa at HPAPI World Congress

Prentice Curry, Vice President Quality and Operations, Kite Pharma Inc

Prentice Curry at HPAPI World Congress

Dr William Dall'Acqua, VP, R&D, MedImmune

Igor D'Angelo, Senior Scientist and Functional Lead, Amgen Inc

Lee Dawson, Senior Scientist, Molecular Pathology Group, Asterand Bioscience

Lee Dawson at HPAPI World Congress

Dr John Delaney, Executive Director, Amgen Biologics Discovery, Amgen

Madiha Derouazi, Chief Executive Officer, Amal Therapeutics

Richard DiCicco, Chairman, Harvest Moon Pharmaceuticals

Richard DiCicco at HPAPI World Congress

Claire Dobson, Associate Director of Antibody Discovery and Protein Engineering, MedImmune

Claire Dobson at HPAPI World Congress

Dr Helena Domingues, Examiner, Joint Cluster Biotechnology, Immunology Directorate, European Patent Office

Dr Helena Domingues at HPAPI World Congress

Wendel Doubleday, Senior Director of Chemical Development, Seattle Genetics Inc

Wendel Doubleday at HPAPI World Congress

Roman Drai, Geropharm

Roman Drai at HPAPI World Congress

Prof Stefan Duebel, Director, Braunschweig University of Technology

Dr Peter Ellmark, Principal Scientist, Immuno-oncology, Alligator Bioscience Ab

Stephan Ewert, Senior Investigator, Novartis Pharma AG

Kalveer Flora, Specialist Pharmacist Rheumatology & Biosimilars, London North West Healthcare Nhs Trust

Kalveer Flora at HPAPI World Congress

Agnete Fredriksen, President and Chief Scientific Officer, Vaccibody As

Per Ola Freskgard, Vice Director & Expert Scientist, Roche Innovation Center Basel

Lothar Germeroth, Senior Vice President and Managing Director, Juno Therapeutics

Lothar Germeroth at HPAPI World Congress

Dr David Gilham, Vice President of Research and Development, Celyad

Dr David Gilham at HPAPI World Congress

Jorge González Borroto, Pharmacovigilance Officer/Senior Toxicologist, Ferrer Internacional, S.A.

Jorge González Borroto at HPAPI World Congress

Eric Halioua, President and Chief Executive Officer, PDC*line pharma SA

Dr Steffen Hartmann, Global Head Integrated Biologics Profiling, Novartis

Andreas Herrmann, Chief Executive Officer, Valerius Biopharma

Andreas Herrmann at HPAPI World Congress

Matthew Hewitt, Director, Tumour Immunology & Microenvironment, Bellicum Pharmaceuticals

Stuart Hicks, Associate Director, ImmunoGen Inc

Stuart Hicks at HPAPI World Congress

Michael Hust, Group Leader, Technical University of Braunschweig

Clare Jacklin, Director, National Rheumatoid Arthritis Society

Clare Jacklin at HPAPI World Congress

Christopher Jewell, Associate Professor & Damon Runyon-Rachleff Innovator, University of Maryland

Christopher Jewell at HPAPI World Congress

Kevin Johnson, Partner, Medicxi

Dr Karin Jooss, Chief Scientific Officer, Gritstone Oncology

Peter Joyce, CEO, Grey Wolf Therapeutics

Meelis Kadaja, Director of Business Development, Icosagen Cell Factory Ltd

Robert Kelley, Principal Scientist, Genentech

Robert Kelley at HPAPI World Congress

James Kent, NHS England

James Kent at HPAPI World Congress

Shirin Khambata Ford, Executive Director of Oncology Biomarker and Diagnostics Leader, Merck Oncology

Shirin Khambata Ford at HPAPI World Congress

Houng Kim, head of the strategy and operations division, Celltrion Healthcare

Houng Kim at HPAPI World Congress

Takashi Kei Kishimoto, Chief Science Officer, Selecta Biosciences Inc

David Klatzmann, Professor, Pierre et Marie Curie University and Medical School

David Klatzmann at HPAPI World Congress

Roland Kontermann, Professor Of Biomedical Engineering, University of Stuttgart

Dr Jiri Kovarik, Research Investigator, N.I.B.R.

Suzette Kox, Senior Director Of International For Biosimilar Medicines Group, Medicines for Europe A.I.S.B.L.

Suzette Kox at HPAPI World Congress

Heinz Läubli, Attending Physician, Medical Oncology, University Hospital Basel

Andreas Hougaard Laustsen, Postdoctoral Fellow, Technical University of Denmark

Emma Lees, Vice President,, N.I.B.R.

Emma Lees at HPAPI World Congress

Zhaoyang (Megan) Li, Director, Translational Medicine & Clinical Pharmacology, Sanofi

Chris Lloyd, Senior Scientist, Protein Engineering, Antibody Discovery and Protein Engineering, MedImmune U.K. Ltd

Chris Lloyd at HPAPI World Congress

Thorsten Lorenz, Group Head of Develop ability Assessment Biologics, Novartis Pharma AG

Thorsten Lorenz at HPAPI World Congress

Juergen Lukas, Boehringer Ingelheim

Juergen Lukas at HPAPI World Congress

Reinhold Maeck, Head of Corporation EH&S Regulatory Intelligence, Boehringer Ingelheim

Reinhold Maeck at HPAPI World Congress

Mark J Mamula, Professor of Medicine Rheumatology, Yale University

Mark J Mamula at HPAPI World Congress

Dr Ivan Mascanfroni, Senior Scientist, Immunology Biologics, AbbVie

Dr Ivan Mascanfroni at HPAPI World Congress

Justin Mason-Home, Director, HPAPI Services Limited

Justin Mason-Home at HPAPI World Congress

Krzysztof Masternak, Head of Biology, NovImmune Sa

Dr Christoph Merten, Group Leader and Principal Investigator Genome Biology Unit, European Molecular Biology Laboratory

Derek Michael Mason, PhD Candidate, ETH Zurich

Enkelejda Miho, Pioneer, ETH Zurich

Vera Molkenthin, Chief Scientist, Abcheck s.r.o.

Dr M. Anthony Moody, Associate Professor of Paediatrics, Assistant Professor of Immunology, Duke University Medical Center

Hans-Martin Mueller, Director, Biotech Development, Millipore S.A.S.

Hans-Martin Mueller at HPAPI World Congress

Prof Dr Dario Neri, Co-founder, Philogen; Department of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology Zurich

Sarfaraz Niazi, Chairman, Professor, Karyo Biologics/UIC

Dr Ahuva Nissim, Reader, William Harvey Research Institute

Benjamí Oller-Salvia, EMBO postdoctoral fellow, M.R.C. Laboratory of Molecular Biology

Dr Shane Olwill, Vice President of Development, Pieris Pharmaceuticals

Hardev Pandha, Professor of Medical Oncology, University of Surrey

Hardev Pandha at HPAPI World Congress

Nora Pencheva, Lead Scientist, Humax-AXL-ADC Program, Genmab

Nicole Piche-Nicholas, Senior Scientist, Pfizer

Nicole Piche-Nicholas at HPAPI World Congress

Abhinandan Raghavan, Data Scientist, Technology and Functional Leader, Informatics, Novartis Pharma AG

Abhinandan Raghavan at HPAPI World Congress

Dr Alexey Rak, Head of Bio Structure and Biophysics, Sanofi

Ulrich Rant, Chief Executive Officer, Dynamic Biosensors

Ulrich Rant at HPAPI World Congress

Dr Fabian Richter, Post-Doctoral Fellow, University of Stuttgart

Theo Rispens, Group Leader, Sanquin

Christoph Roesli, Senior Fellow, Global Drug Development, Novartis Pharma AG

Yun Sanders, Senior scientist, Crescendo Biologics

Andreas Schreiner, Director of Validation, Manufacturing Science and Technology, Novartis Ag

Andreas Schreiner at HPAPI World Congress

Darko Skegro, Senior Investigator, Biotherapeutic Technologies, Novartis Institutes for Biomedical Research

Alan K. Smith, Executive Vice President, Technical Operations, Bellicum Pharmaceuticals

Anke Steinmetz, Senior Scientist, Integrated Drug Discovery/Structure, Design & Informatics, Sanofi

Anke Steinmetz at HPAPI World Congress

Pawel Stocki, Senior Principal Scientist, Ossianix, Inc.

Dr Michael Streit, Sr Director Clinical Research Lead, Janssen

Cian Stutz, Principal Scientist, Antibody Engineering, Glenmark Pharmaceuticals

Lioudmila Tchistiakova, Senior Director of Global Biotherapeutic Technologies, Pfizer

Lioudmila Tchistiakova at HPAPI World Congress

Greg Thurber, Assistant Professor of Chemical Engineering, University of Michigan

Greg Thurber at HPAPI World Congress

Pascal Touchon, Senior Vice President and Global Head Cell & Gene, Novartis

Pascal Touchon at HPAPI World Congress

Dr Frédéric Triebel, Chief Scientific Officer and Medical Officer, Immutep Ltd

Dr Mihriban Tuna, Vice President, Drug Discovery, F-Star

Wouter Verdurmen, Assistant Professor, Radboud University Medical Center

Dr Alain Vertes, Managing Director, NxR Biotechnologies

Meenu Wadhwa, Section Leader for Cyotkines and Growth Factors Section, NIBSC

Meenu Wadhwa at HPAPI World Congress

Dr Carl Webster, Principal Scientist, Antibody Discovery and Protein Engineering, MedImmune Cambridge

Dr Martin Welschof, Chief Executive Officer, Opsona Therapeutics Ltd

Dr Jens Würthner, Head of Clinical Development – EU, ADC Therapeutics

Wei Xu, Principal Scientist, Analytical Method Development, Merck Research Laboratories

Ildiko Ziegler, Distinguished Validation Expert, Gedeon Richter Plc

Ildiko Ziegler at HPAPI World Congress

 

 

HPAPI World Congress 

HPAPI World Congress

Wendel Doubleday , Sr Director, Process Research and Development, Seattle Genetics 
Karoline Betchtold Peters
, Senior Strategy & Technology Leader - Pharmaceutical Development, Novartis
Justin Mason Home,
Director, HPAPI Project Services Ltd
Martin Axon
, Principle Occupational Hygienist, SafeBridge  
Marc Abromovitz
, Director, Occupational Health and Hygiene, Novartis  
Ildiko Ziegler
, Distinguished Validation Expert, Gedeon Richter
Reinhold Maeck
, Associate Director Tech-Transfers, Boehringer Ingelheim
Andreas Schreiner
, Director of Validation, Manufacturing Science and Technology, Novartis 
González Borroto
, Pharmacovigilance Officer/Senior Toxicologist, Ferrer Internacional, S.A.Toral 
Toral Mehta
, Head of Industrial Hygiene and Containment, Sandoz 
Jack Brown
, Sr Principle Scientist, Boehringer Ingelheim
Juergen Knoebel
, Senior Advisor - Global Technical Operations Quality Systems/Quality Management, Roche
Alessandro Brigo
, Principal Scientist, Roche

 


World Immunotherapy Congress

Ahuva Nissim , Reader in Antibody and Therapeutic Engineering Biochemical Pharmacology, William Harvey Research Institute, Queen Mary University
Alain Vertes , Managing Director, NxR Biotechnologies
Daniela Cipolletta
, Lab Head, Investigator III, Immuno-Oncology, Novartis
Dario Neri
, Founder, Philogen; Professor of Chemistry and Applied Biology, Swiss Federal Institute of Technology Zurich
Eric Halioua
, President and Chief Executive Officer, PDC*line Pharma
Frédéric Triebel
, Chief Scientific Officer, Chief Medical Officer, Prima BioMed
Hans-Peter Gerber
, CSO, Maverick Therapeutics
Joern Schmitz
, Head, Department of Immunotherapy, Fraunhofer IME
Jose Saro
, Senior Translational Medicine Leader, Roche
M. Anthony Moody
, Associate Professor, Department of Paediatrics, Division of Infectious Diseases, Duke University Medical Centre
Martin Welschof
, Chief Executive Officer, Opsona Therapeutics
Martina Canestraro
, Senior Research Scientist, Immunocore
Roy Baynes
, SVP and Head Global Clinical Development, Chief Medical Officer, Merck, Sharp & Dohme (MSD)
Shane Olwill
, Head of Immuno-Oncology, Pieris Pharmaceuticals 
Sidath Katagampola
, Biomarker Development Sciensist, Centre for Drug Development, Cancer Research UK

 

European Antibody Congress

Alain Beck , Senior Director, NBEs Analytical Chemistry, Pierre Fabre ; Associate Editor, mAbs 
Alexey Rak
, Head of Bio Structure and Biophysics, S anofi R&D
Andreas Hougaard Laustsen
, Postdoctoral Fellow, Tropical Pharmacology Lab, Technical University of Denmark 
Carl Webster, Principal Scientist
, Antibody Discovery and Protein Engineering, MedImmune
Christoph Merten
, Group Leader Microfluidics, European Molecular Biology Laboratory
Darko Skegro
, Senior Investigator, Biotherapeutic and Analytical Technologies, NIBR
Ezio Bonvini
, MD - CSO, Macrogenics
Fabian Richter
, Post-Doc, University of Stuttgart
Frank Brennan
, Senior Director, UCB Celltech
Frank Walsh
, CEO, Ossianix
Helena Domingues
, Examiner, Joint Cluster Biotechnology, Immunology Directorate, European Patent Office
Igor D’Angelo
, Team Lead, Antibody Engineering, Amgen British Colombia 
Ivan Mascanfroni
, Senior Scientist, Immunology Biologics, AbbVie
Janice Reichert
, Executive Director, The Antibody Society ; Editor-in-Chief, mABs
Jens Würthner
, Assistant Vice President, Head of Clinical Development – EU, ADC Therapeutics
Jiri Kovarik
, Research Investigator, Novartis
John Delaney
, Executive Director of Research, Amgen
Krzysztof Masternak
, Head of Biology, NovImmune
Michael Streit
, Senior Director, Clinical Leader Research, Translational Medicine and Early Development, Oncology, Janssen
Nathalie Corvaia
, Director, CIPF, Pierre Fabre
Oliver Spadiut
, Assistant Professor, Integrated Bioprocess Development, TU Wien
Patrick Burke
, Associate Director of Chemistry, Seattle Genetics
Peter Ellmark
, Principal Scientist, Immuno-Oncology, Alligator Bioscience
Peter Senter
, VP, Distinguished Research Fellow, Seattle Genetics
Roy Baynes
, SVP and Head Global Clinical Development, Chief Medical Officer, Merck, Sharp & Dohme (MSD)
Senior representative, AbCheck
Senior representative, Abzena
Senior representative, Acro Biosystems
Senior representative, BioVT
Senior representative, Fujifilm Diosynth Biotechnologies
Senior representative, Icosagen
Senior representative, Isogenica
Senior representative, KBI Biopharma
Stefan Dübel , Director, Department of Biotechnology, Technische Universität Braunschweig
Theo Rispens , Group Leader, Sanquin
Thomas Huber , Senior Investigator II, Technology Leader, Multispecific Modalities, Novartis Instituted for BioMedical Research
Ulrich Brinkmann
, Scientific Director, Roche Pharma Research & Early Development, Roche Innovation Centre Munich
William D’all Acqua
, Vice President of R&D, MedImmune
Zhaoyang (Megan) Li
, Director Clinical Pharmacology, Sanofi

 


Clinical Trials


Stephen Nabarro , Head Clinical ops and data, Cancer Research UK
Jonathan Sheffield
, CEO, NIHR
Jim Kremidas,
 Director,  Association of Clinical Research Professionals 
Andy Lee
, Head of Global Clinical Trial Operations, Novartis 
Eileen Dergarabetian
, Head of Medical Information and engagement, Novartis
Joana Claverol
, Clinical Research Unit Manager, Sant Joan de Deu Barcelona Children's Hospital, Research Foundation
Suvodip Shaw
, Global Central Monitoring Operations Manager, Novartis

 


World Biosimilar Congress


Adam Levysohn , Sr Director Market Access Biosimilar, Biogen
Alain Beck
, Senior Director Analytical Chemistry, CIPF and Associate Editor, mAbs
Alain Vertes
, Managing Director, NxR Biotechnologies
Ber Oomen
, Executive Secretary, European Specialist Nurses Organisations
Cecil Nick
, Vice President, Biotechnology, PAREXEL
Divya Chadha Manek
, Head of Commercial Business Development & Marketing, NIHR Clinical Research Network (NIHR CRN)
Gianluca Trifirò
, Department of Biomedical Sciences, Dentistry and Morphological and Functional Images, University of Messina – Italy
Ian Henshaw
, Global Head of Business Operations and Alliance Management, Biogen
Ingrid Schwarzenberger
, Head Global Regulatory Affairs, Sandoz Biopharmaceuticals
Jatinder Harchowal
, Chief Pharmacist / Clinical Director, Medicines Management & Clinical Support Services Business Unit, Pharmacy Dept, The Royal Marsden NHS Foundation Trust
Jonathan Underhill
, Medicines Clinical Adviser, Medicines and Technologies Programme (MTP), NICE
Karsten Roth
, Director Clinical Operations and Pharmacovigilance, Cinfa Biotech GmbH
Philip Ball
, Market Access Manager, NAPP Pharmaceuticals
Ruediger Jankowsky
, Managing Director, Cinfa Biotech GmbH
Shantreddy Soogareddy
, Associate Director External R&D, Dr. Reddy's Laboratories SA.
Steinar Madsen
, Medical Director, Norwegian Medicines Agency
Tim Shea
, Director, Sterne, Kessler, Goldstein & Fox
Uwe Gudat
, Head of Safety, Biosimilars, Merck

 

 

 

2017 Speakers

 

Marc Abromovitz, Head, Industrial Hygiene, Novartis

Marc Abromovitz at HPAPI World Congress

Michael Avraam, Global Product Manager, ChargePoint Technology Ltd

Michael Avraam at HPAPI World Congress

Martin Axon, Principal, Occupational Hygienist of Operations for Europe, Safebridge

Martin Axon at HPAPI World Congress

Karoline Bechtold Peters, Senior Strategy & Technology Leader - Pharmaceutical Development, F. Hoffmann-La Roche Ltd

Karoline Bechtold Peters at HPAPI World Congress

Roger Beerli, CSO, NBE Therapeutics

Roger Beerli at HPAPI World Congress

Stefano Butti, Head of Sales Group, F.P.S. Food and Pharma Systems Srl

Stefano Butti at HPAPI World Congress

Jorge González Borroto, Pharmacovigilance Officer/Senior Toxicologist, Ferrer Internacional, S.A.

Jorge González Borroto at HPAPI World Congress

Helena Hemming, Senior Occupational Toxicologist, AstraZeneca

Helena Hemming at HPAPI World Congress

Ulf Johansson, Project Manager, AstraZeneca

Ulf Johansson at HPAPI World Congress

Olindo Lazzaro, Director, Environment, Health & Safety, AbbVie

Olindo Lazzaro at HPAPI World Congress

Ester Lovsin Barle, Head of Health Hazard Assessment Center of Excellence, Lonza

Ester Lovsin Barle at HPAPI World Congress

Reinhold Maeck, Head of Corporation EH&S Regulatory Intelligence, Boehringer Ingelheim

Reinhold Maeck at HPAPI World Congress

Sara Martens, Senior Manager, OH/Containment, AbbVie

Sara Martens at HPAPI World Congress

Justin Mason-Home, Director, HPAPI Services Limited

Justin Mason-Home at HPAPI World Congress

Steve McAleavy, Director, Ezi Dock Systems Ltd

Steve McAleavy at HPAPI World Congress

Rainer Nicolai, Technical Specialist, F. Hoffmann-La Roche Ltd

Rainer Nicolai at HPAPI World Congress

Jeff Parry, Senior Scientist Manufacturability, AstraZeneca

Jeff Parry at HPAPI World Congress

Aurore Perzyna, Head of Production, Oril Industrie

Aurore Perzyna at HPAPI World Congress

Sylvain Querol, European Technical and Tendering Manager, Powder Systems Limited (PSL)

Sylvain Querol at HPAPI World Congress

Andreas Schreiner, Director of Validation, Manufacturing Science and Technology, Novartis Ag

Andreas Schreiner at HPAPI World Congress

Claudia Sehner, Principal Scientist Toxicology, Boehringer Ingelheim Pharma GmbH & Co. KG

Claudia Sehner at HPAPI World Congress

Marc Suter, Sr Sales Manager, Skan A.G.

Marc Suter at HPAPI World Congress

Silke Weber, Toxicology Project Lead, Roche

Silke Weber at HPAPI World Congress

Sir Gregory Winter, Master, Trinity College Cambridge, University of Cambridge

Sir Gregory Winter at HPAPI World Congress

Ildiko Ziegler, Distinguished Validation Expert, Gedeon Richter Plc

Ildiko Ziegler at HPAPI World Congress

 

APPLY TO SPEAK

Mark Your Calendars Now!
Conference 29 - 31 October • Exhibition & Seminars 29 - 31 October 

Sign Up for Event Updates